| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
13.010 |
Evidence |
|
| BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
LEPR |
LEPR, DB, OBR: Leptin receptor precursor |
13.010 |
Evidence |
|
| IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
STAT3 |
|
13.010 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
RGS19 |
RGS19, GAIP, GNAI3IP: Regulator of G-protein signaling 19 |
13.010 |
Evidence |
|
| GHR |
GHR: Growth hormone receptor precursor |
STAT3 |
|
13.010 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
13.010 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
TIAM1 |
TIAM1: T-lymphoma invasion and metastasis-inducing protein 1 |
13.010 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
MAPK8 |
MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 |
13.010 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
13.010 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
RAB4A |
IPI00549945 |
13.010 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
PTPRC |
PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ |
13.010 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
PTPRE |
PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor |
13.010 |
Evidence |
|
| CGA |
CGA: Glycoprotein hormones alpha chain precursor |
ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
13.010 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
IGFBP7 |
IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor |
13.010 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
VASP |
VASP: Vasodilator-stimulated phosphoprotein |
13.010 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
NF2 |
NF2, SCH: Merlin |
13.010 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
MT2A |
MT2A, CES1, MT2: Metallothionein-2 |
13.010 |
Evidence |
|
| NBN |
NBN, NBS, NBS1, P95: Nibrin |
RAD50 |
RAD50: DNA repair protein RAD50 |
13.010 |
Evidence |
|
| LAT |
LAT: Linker for activation of T-cells family member 1 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
13.010 |
Evidence |
|
| LAT |
LAT: Linker for activation of T-cells family member 1 |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
13.010 |
Evidence |
|
| LAT |
LAT: Linker for activation of T-cells family member 1 |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
13.010 |
Evidence |
|
| CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
PSEN1 |
PSEN1, AD3, PS1, PSNL1: Presenilin-1 |
13.010 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
AMHR2 |
AMHR2, AMHR: Anti-Muellerian hormone type-2 receptor precursor |
13.010 |
Evidence |
|
| TNFSF8 |
TNFSF8, CD30L, CD30LG: Tumor necrosis factor ligand superfamily member 8 |
TNFRSF11B |
TNFRSF11B, OCIF, OPG: Tumor necrosis factor receptor superfamily member 11B prec |
13.010 |
Evidence |
|
| IL1A |
IL1A, IL1F1: Interleukin-1 alpha precursor |
IL1RAPL1 |
IL1RAPL1, OPHN4: X-linked interleukin-1 receptor accessory protein-like 1 precur |
13.010 |
Evidence |
|